Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study
To inform guidelines for screening family members of patients with familial hypercholesterolemia (FH), we designed a clinical trial to compare the yield of cascade screening in FH patients with and without an identifiable pathogenic variant. Participants with hypercholesterolemia (Low-density lipopr...
Main Authors: | Iftikhar J. Kullo, Kent R. Bailey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4426/8/3/27 |
Similar Items
-
ASPECTS OF DETECTING PATIENTS WITH FAMILY HYPERCHOLESTEROLEMIA
by: P M Kurbanismailova, et al.
Published: (2017-09-01) -
Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis
by: Candace L. Jackson, et al.
Published: (2021-12-01) -
CASCADE GENETIC SCREENING IN DIAGNOSTICS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: CLINICAL CASE
by: E. V. Shakhtshneider, et al.
Published: (2017-07-01) -
Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia
by: Carla G. van El, et al.
Published: (2018-08-01) -
Familial Hypercholesterolemia: A Systematic Review of Guidelines on Genetic Testing and Patient Management
by: Giuseppe Migliara, et al.
Published: (2017-09-01)